On this page
QDPR
quinoid dihydropteridine reductase
The QDPR gene provides instructions for making an enzyme crucial for recycling tetrahydrobiopterin (BH4), a molecule essential for processing amino acids and producing neurotransmitters. The QDPR gene is responsible for producing the enzyme quinoid dihydropteridine reductase.
QDPR is located on the short (p) arm of chromosome 4, at band 4p15.32. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 4 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The QDPR gene, also known as quinoid dihydropteridine reductase, is fundamental for human metabolism. It encodes an enzyme that is an integral part of the biochemical pathway responsible for recycling tetrahydrobiopterin (BH4).
Tetrahydrobiopterin is a vital cofactor that facilitates the proper functioning of several enzymes. These enzymes are involved in the processing of amino acids and the production of neurotransmitters, which are chemical messengers in the brain. Dysfunction of the QDPR gene can disrupt these critical processes, leading to specific health conditions.
What the gene does
The QDPR gene provides the blueprint for an enzyme named quinoid dihydropteridine reductase. This enzyme is specifically involved in the chemical pathway that recycles tetrahydrobiopterin (BH4).
Tetrahydrobiopterin itself acts as a cofactor, assisting other enzymes in various metabolic reactions. For instance, it works with phenylalanine hydroxylase to convert the amino acid phenylalanine into tyrosine. Beyond amino acid processing, BH4 is also essential for the synthesis of neurotransmitters, which are crucial for transmitting signals between nerve cells. Once BH4 has participated in these reactions, it undergoes alteration and must be regenerated to its active form. Quinoid dihydropteridine reductase is one of two enzymes responsible for this recycling process, ensuring a continuous supply of functional BH4 for the body's metabolic needs.
Video: Genetics 101
Chromosome location
The QDPR gene is located on chromosome 4, specifically at position 4p15.32. This indicates its precise address on the short arm of chromosome 4. The gene's coding sequence ultimately directs the assembly of a protein composed of 244 amino acids.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Genetic variations within the QDPR gene can impact the function of the quinoid dihydropteridine reductase enzyme. These variations, often referred to as mutations, can alter the protein's structure or reduce its ability to effectively recycle tetrahydrobiopterin. Over 30 different mutations have been identified in the QDPR gene.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.278del | p.Gly93fs | Pathogenic/Likely pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.344C>T | p.Ser115Leu | Pathogenic/Likely pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.421del | p.Leu141fs | Pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.436+2552A>G | - | Pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.449A>G | p.Tyr150Cys | Pathogenic | ★★☆☆ | QDPR-related disorder |
c.472C>T | p.His158Tyr | Pathogenic/Likely pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.523del | p.Ala175fs | Pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.545+1G>A | - | Pathogenic | ★★☆☆ | QDPR-related disorder |
c.609dup | p.Pro204fs | Pathogenic/Likely pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
c.661C>T | p.Arg221Ter | Pathogenic | ★★☆☆ | Dihydropteridine reductase deficiency |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Mutations in the QDPR gene are known to cause Dihydropteridine reductase deficiency. This condition is a form of tetrahydrobiopterin deficiency and accounts for approximately one-third of all diagnosed cases of tetrahydrobiopterin deficiency. The deficiency primarily affects the body's ability to process certain amino acids and produce neurotransmitters.
Inheritance pattern
Conditions caused by pathogenic QDPR variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The QDPR gene is included in several UK NHS national genomic testing panels, indicating its clinical relevance within the Genomic Medicine Service. It is listed as 'green' on panels such as DDG2P, Dystonia, chorea or related movement disorder (childhood onset), Intellectual disability, Likely inborn error of metabolism, Neurotransmitter disorders, and Undiagnosed metabolic disorders.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the QDPR gene?
The QDPR gene provides instructions for an enzyme called quinoid dihydropteridine reductase, which is essential for recycling tetrahydrobiopterin (BH4), a crucial cofactor for processing amino acids and synthesising neurotransmitters.
What condition is associated with mutations in the QDPR gene?
Mutations in the QDPR gene cause Dihydropteridine reductase deficiency, which is a specific type of tetrahydrobiopterin deficiency affecting amino acid metabolism and neurotransmitter production.
How common is Dihydropteridine reductase deficiency?
Dihydropteridine reductase deficiency, caused by QDPR gene mutations, accounts for approximately one-third of all cases of tetrahydrobiopterin deficiency.
References
- Longo N. Disorders of biopterin metabolism. Journal of inherited metabolic disease. 2009. PMID: 19234759
- Thöny B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Human mutation. 2006. PMID: 16917893
- Ponzone A, Spada M, Ferraris S. Dihydropteridine reductase deficiency in man: from biology to treatment. Medicinal research reviews. 2004. PMID: 14705166
- Shintaku H. Disorders of tetrahydrobiopterin metabolism and their treatment. Current drug metabolism. 2002. PMID: 12003346
- Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. The Biochemical journal. 2000. PMID: 10727395
- Romstad A, Kalkanoğlu HS, Coşkun T. Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE). Human genetics. 2000. PMID: 11153907
- Dianzani I, de Sanctis L, Smooker PM. Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations. Human mutation. 1998. PMID: 9744478